Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Prostate Cancer
2		Additional conditions recognized in this trial
			Prostatic Neoplasms
3		More general conditions related to this trial
			Genital Diseases, Male
			Genital Neoplasms, Male
			Neoplasms
			Neoplasms by Site
			Prostatic Diseases
			Urogenital Neoplasms
4		Interventions listed in this trial
			PSA prostate cancer vaccine
			recombinant interleukin-12
5		Additional drug interventions recognized in this trial
			Interleukin-12
6		More general drug interventions related to this trial
			Adjuvants, Immunologic
			Angiogenesis Inhibitors
			Angiogenesis Modulating Agents
			Antineoplastic Agents
			Growth Inhibitors
			Growth Substances
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			University of Chicago
			National Cancer Institute (NCI)